At a glance
ClinicalIndex Comparison Record- ✓Age ≥18 years
- ✓Stakeholder participants (patient advisory council members, health system leaders, clinicians, clinic staff, IT/informatics staff) OR patients with suspected thoracic, gastrointestinal, or gynecologic cancer undergoing surgery OR patients with confirmed thoracic, gastrointestinal, or gynecologic cancer starting new treatment
- ✓Priority patient populations include those with suspected/confirmed thoracic cancer (lung/bronchus), gastrointestinal cancer (colorectal, pancreas, liver/biliary, esophagus, gastric), or gynecologic cancer (ovary, uterus, cervix)
- ✓Any patient at any participating site may use eSyM (total population)
- ✕Participants not meeting inclusion criteria
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology Practice
In Brief
A clinical study evaluating Stakeholder Survey (Control Period), Stakeholder Survey (Intervention Period), and 3 other interventions for Other Cancer and 3 related conditions. Completed, enrolled 42,808 participants across 6 sites.
Detailed Summary
Deficits in the management of common symptoms cause substantial morbidity for cancer patients.Because the health care delivery system is structured to be reactive and not proactive, there are missed opportunities to optimize symptom control. Growth in Internet access and proliferation of smartphones has created an opportunity to re-engineer cancer care delivery. Electronic symptom tracking and feedback is a promising strategy to improve symptom control. Electronic patient reported outcome (ePRO) monitoring of cancer symptoms has been shown to decrease symptom burden, improve quality of life, reduce acute care and even extend survival. SIMPRO will use functioning ePRO prototypes to create and refine the electronic symptom management system eSyM
Study Details
Timeline
Interventions
Before eSyM go-live, study team members from each site will solicit input via emailed survey, remote meetings and/or in-person meeting on the use of ePROs in oncology from stakeholders to obtain input regarding adaptation, anticipated challenges, and implementation.
After eSyM go-live and on an ongoing basis, we will evaluate the implementation process at each of the sites with a focus on adoption, appropriateness, acceptability, sustainability, penetration, and scalability. We will do so through emailed surveys and/or discussions with health system leadership, clinicians, clinic support staff, and informatics/IT staff.
A small subset of patients and stakeholders were invited to take part in qualitative interviews after the eSyM trial rollout.
A subset of control and intervention patients will be asked to complete a research questionnaire called the "SASS Questionnaire" asking about their Self-efficacy, Attainment of information needs, Symptom burden, and Satisfaction with care.
The electronic symptom management (eSyM) program is the EHR-integrated ePRO program being evaluated through this trial.